Appointments
Biotech company CSL has appointed Dr Paul McKenzie as its Chief Executive Officer (CEO) and Managing Director. Dr McKenzie is currently serving as CSL's Chief Operating Officer (COO) and will immediately join the Board of Directors as an Executive Director and will become CEO and Managing Director on March 6, 2023. Dr McKenzie has more [...]
Akron Bio, a provider of critical inputs for cell and gene therapies, has announced the appointment of Christopher Murphy as Chief Executive Officer (CEO). A biotechnology industry veteran, Murphy has more than 30 years of experience in advanced therapy and biological drug development and manufacturing. Most recently, Murphy served as Vice President and General Manager [...]
Signant Health has announced the appointment of Graciela Racaro as chief operating officer (COO). Racaro will leverage her clinical operations and regulatory expertise to drive operational efficiency at scale and enhanced the customer experience. Graciela Racaro said: "This is an exciting time to join Signant. "As clinical development evolves towards greater globalisation and digitalisation, Signant [...]
Health and wellness company Hims & Hers Health, Inc. has appointed Dr Scott Knoer, Pharm.D., MS, FASHP, as Chief Pharmacy & Innovation Officer. The company enables access to treatments for a broad range of conditions, including those related to sexual health, hair loss dermatology, mental health and primary care. Dr Knoer will oversee pharmacy strategy [...]
Proactive wellness services company Restore Hyper Wellness has announced the appointment of Richard Joseph, MD as Chief Medical Officer (CMO). Dr Joseph will be responsible for clinical guidance of medical modalities and protocols, with the company now surpassing 175 wellness studios across nearly 40 states. Dr Joseph has extensive experience f healthcare and fitness industries. [...]
Strand Therapeutics has added an additional $45M to its Series A financing round, bringing the total amount raised to $97 million. Strand is a programmable mRNA company developing curative therapies for cancer and other diseases. The round was led by new investor FPV, with participation from Eli Lilly and Company, Potentum Partners, and existing investors [...]
Contract Research, Development & Manufacturing Organisation (CRO-CDMO Sai Life Sciences has announced the appointment of Stephen Hermitage as Vice President, CMC. Hermitage will join the global R&D leadership team at Sai Life Sciences, where he will add further deep scientific, process development and drug development experience to the R&D organisation. Hermitage joins Sai Life Sciences [...]
The LINK Medical Board has announced the appointment of Sissel Lønning Andresen as the company’s new CEO. Andresen will assume the position of CEO on January 1, 2023. Ola Gudmundsen will remain with the company in a strategic role where he will work closely with Andresen and support the Business Development and Commercial Operations team. [...]
Private biotech company Lucy Therapeutics, Inc. has announced the appointment of business-side biopharma leader Julia Gaebler, Ph.D., as Chief Business Officer (CBO). Dr Gaebler has more than 25 years of business development and strategy experience in the life sciences industry, spanning biopharma, consulting and academia. The new CBO will direct Lucy Therapeutics’ fundraising, growth and [...]
Personalised hormone therapy company Biote Corp has announced the appointment of Debby Morris to Biote’s Board of Directors. Biote trains practitioners how to identify and treat early indicators of hormone-related ageing conditions, providing affordable symptom relief for patients. Morris has more than three decades of experience in directing financial operations and strategy to support high-growth [...]
